We use cookies to improve your online experience. By continuing browsing this website, we assume you agree our use of cookies.

Chlorhexidine Gluconate CHG Applicator Fast Acting Antiseptic Polyethylene Handle

Item No.: 00078
  • Material:
    long plastic handle with 2% chlorhexidine gluconate (CHG) and 70% isopropyl alcohol (IPA) liquid
Description
Description

Cleanmo’s CHG Prep Applicator is a medical applicator which is used for skin antisepsis preparation, it is made of medical grade 100PPI open-cell polyurethane foam and  white PE ( Polyethylene ) handle. It is with formulation of 2% Chlorhexidine gluconate (CHG) and 70% isopropyl alcohol (IPA) to meet the strict clinical requirements of FDA, thus it would kill more bacteria than traditional Iodophor swabs and Alcohol swabs. CHG Prep Applicators have been widely used for CDC (Center for Disease Control and Prevention), INS (Infusion Nurses Society), SHEA (Society for Healthcare Epidemiology of America) and IDSA (Infectious Diseases Society of America).

Reasons you should pick Chlorex applicator:
Cleanmo

 More effective at reducing skin bacteria than other antiseptics

 Exhibits a rapid & persistant bactericidal activity without irritating the skin

 Active in protein-rich biomaterials

Characteristics
Cleanmo

 Tip made of medical-grade foam :soft, inert and hypoallergenic,release fewer particles than gauze

 Maxi size applicators allow for the antisepsis of a large surface of skin 4 in x5 in.

 Eliminate the need for forceps, gauze swabs, bowls and bottled solutions.

 Impregnated with 5ml of 2% W/V Chlorhexidine Gluconate and 70% V/V Isopropyl Alcohol:

   - Fast-acting antiseptic, with a residual activity for over 24 hours

   - Antiseptic not affected by contact with organic matter, unlike Iodophor solutio

   - Antiseptic effective against Gram positive bacteria, Gram negative bacteria, fungi and viruses

   - Solution that dried quickly

 Available in clear or tinted solution

❈ Indications

Indications
Cleanmo

 Design is convenient for use in Operation Room,Obstetrics, Radiology,Emergency Room and Care

 Skin asepsis covering a surface of  4 in x 5 in for

 punctures and biopsies

❈ Drawing and Size


SPECIFICATION
Part. NO Size Packing Liquid Color

SASP-030-2C7I

3 ml

1 piece/ bag

Orange / Transparent 

SASP-050-2C7I

5 ml

SASP-060-2C7I

6 ml

❈ Packing

Packing
Cleanmo

Individual package 

Part No.: SA-030-2C7I | 3ml | 100 pieces/box

  Part No.: SA-050-2C7I | 5ml  | 100 pieces/box

 Part No.: SA-060-2C7I | 6ml  | 100 pieces/box

❈ Direction for use

                           
Step1
Pull and remove the ring collar lock from the handle, do not touch the foam pad 
                           
Step 2
Press down to activate and release antiseptic solution to the foam pad .
                           
Step 3
Completely wet the treatment area with antiseptic solution, using gentle back-and-forth strokes, progressing from the incision site to the periphery of the surgical field

❈ Additional information

Additional information
Cleanmo

 Use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.

 Discard the Swab Stick after a single use.

 The Foam is latex-free and for external use. 

 Use in a well-ventilated area.

 Do not use for lumbar puncture or in contact with the meninges. 

 Do not use on open wounds or as a general skin cleanser.

 Do not use on patients with known allergies to CHG or IPA.

 Store between 15 to 30 ° C (59 to 86 ° F).

 Keep the solution out of the eyes, ears and mouth.

 Avoid freezing and excessive heat above 40 ° C (104 ° F). Store within the recommended conditions to maintain the efficacy  

❈ Product Application

Product Application
Cleanmo

-  Pre injection & Preoperative Procedure

-  Peripheral IV insertions and restarts

-  Dialysis procedures

- Routine venipunctures

-  Percutaneous device insertions

-  Simple biopsies

- Vascular Access Insertion & Maintenance

-  Routine catheter maintenance

- Arterial blood gas collections

- Surgical site cleansing after suturing

- Arterial venous fistulas (AVF)/arterial venous graphs (AVG)

Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code